ARTIVION, INC. AORT

About ARTIVION, INC. (AORT): stock profile, AI score and financials

ARTIVION, INC. (AORT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AORT at 47.9/100 on a composite quality score built from its SEC filings, placing it at rank #1,771 of 2,925 stocks — the bottom half of the AI-ranked universe. AORT scores in the top quartile across earnings quality (97.6). Areas of concern include free cash flow (23.7) and balance sheet strength (32.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ARTIVION, INC. reports quarterly revenue of $125.8M, net income of $-13.5M, an operating margin of -6.7%. Top institutional holders of AORT by reported 13-F value include BlackRock, NOMURA ASSET MANAGEMENT INTERNATIONAL, MORGAN STANLEY, based on the most recent SEC filings. AORT trades on the NYSE exchange and files with the SEC under CIK 784199. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AORT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ARTIVION, INC. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 784199 →